SAN DIEGO, April 4, 2013 /PRNewswire/ -- Ajinomoto Co.,
Inc. ("Ajinomoto Co."; TYO: 2802) and Althea Technologies, Inc.
("Althea Technologies"), have completed the previously announced
acquisition of Althea Technologies, a leading provider of
biopharmaceutical development and manufacturing services.
(Logo:
http://photos.prnewswire.com/prnh/20121024/LA98976LOGO)
Ajinomoto acquired all the capital stock of Althea at closing
for a purchase price of approximately $175
million dollars (USD). Althea will become a fully
consolidated subsidiary of Ajinomoto Co., Inc. operating under the
company name Ajinomoto Althea, Inc.
About Ajinomoto Co.
Ajinomoto Co. is a global
manufacturer of high-quality seasonings, processed foods,
beverages, amino acids, pharmaceuticals and specialty chemicals.
For many decades Ajinomoto Co. has contributed to food culture and
human health through wide-ranging application of amino acid
technologies. Today, the company is becoming increasingly involved
with solutions for improved food resources, human health and global
sustainability. Founded in 1909 and now operating in 26 countries,
Ajinomoto Co. had net sales of JYP 1,197.3 billion (USD 15.1 billion) in fiscal 2011. For more about
Ajinomoto Co. (TYO: 2802), visit www.ajinomoto.com.
About Althea Technologies
Althea Technologies is a
fully integrated, contract development and manufacturing
organization located in San Diego,
CA providing clinical and commercial product development
services. Althea Technologies offers cGMP drug product filling in
both vials and syringes, and production of microbial-derived
recombinant proteins and plasmid DNA. In conjunction with these
manufacturing operations, Althea Technologies offers comprehensive
development services including: upstream and downstream process
development, analytical development, lyophilization cycle, complex
formulation, product release and ICH-compliant stability testing.
Althea Technologies' formulation technology platform includes
Crystalomics®, a proprietary technology that offers a formulation
solution for large molecule products that must be delivered at high
concentrations or as sustained release formulations. For more
information, visit www.altheatech.com.
SOURCE Ajinomoto Althea, Inc.